• Summary

    Natural products offer a potential chance in the control and prevention of various diseases, particularly with the increasing prevalence of drug-resistant infections. Edible plants played a crucial role as a valuable source of natural products owing to their availability, variability, and relatively low price. Endophytic fungi with their species diversity are capable of production of a variety of bioactive metabolites that act as a source of novel pharmaceutically active compounds. Endophytic fungi isolated from these edible plants can be used as a great alternate and sustainable source of bioactive secondary metabolites primarily produced by the plants. Secondary metabolites produced by endophytes possess higher therapeutic and pharmaceutical value. Fungal metabolites are the target of our research for the purpose of finding new useful antimicrobial drugs; particularly, when Antimicrobial Resistance (AMR) has exceeded all limits after many world’s prevailing pandemics. Furthermore, these lead molecules can be obtained abundantly in gram amounts thus solving the supply problem of bioactive natural products.

  • Achievements


  • List of Publications from the Project


  • Partners

  • Project Members

  • Project Leaders

  • Project PI

    Omayma Eldahshan

  • Faculty

    Faculty of Pharmacy

  • Research Group

  • Funding Agency

    Ain Shams University - ASU

  • Funding Program

    ASU

  • Start Date

    2023-01-01

  • End Date

    2022-12-31

  • Sustainable Development Goals (SDGs)

    • 3: Good Health and Well-being
    • 6: Clean Water and Sanitation
    • 8: Decent Work and Economic Growth
    • 11: Sustainable Cities and Communities
    • 15: Life on Land
  • Project website